40,000 cancer patients join quest for predictive biomarkers
NCT ID NCT06851975
First seen May 29, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This study is building a massive biobank by collecting blood samples from 40,000 cancer patients during routine care. Researchers will use these samples to look for biomarkers—biological clues—that might predict how a patient will respond to treatment or how long they might survive. The goal is to support future research projects that could lead to more personalized cancer care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Antoine Lacassagne
RECRUITINGNice, 0600, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this biobank could help researchers discover biomarkers that predict how well a cancer patient will respond to treatment or survive, potentially guiding more personalized care in the future.
What could go wrong
This is an observational study that only collects samples for future research—it does not test any treatment. The actual biomarker discoveries and their benefits are years away and may not pan out.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.